| Original language | English |
|---|---|
| Pages (from-to) | 1044-1046 |
| Number of pages | 3 |
| Journal | JACC: Clinical Electrophysiology |
| Volume | 8 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published or Issued - Aug 2022 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: JACC: Clinical Electrophysiology, Vol. 8, No. 8, 08.2022, p. 1044-1046.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Abnormal Cardiac Remodeling in Postural Orthostatic Tachycardia Syndrome
T2 - Further Insights Into its Cardiac Origin
AU - Malik, Varun
AU - Nguyen, Mau T.
AU - Seeley, Marie Claire
AU - Thiyagarajah, Anand
AU - Elliott, Adrian D.
AU - Arnolda, Leonard F.
AU - Sanders, Prashanthan
AU - Lau, Dennis H.
N1 - Funding Information: Drs Malik and Thiyagarajah are supported by an Australian Postgraduate Award Scholarship from the University of Adelaide. Dr Elliott is supported by a Future Leader Fellowship from the Heart Foundation of Australia. Dr Sanders is supported by a Practitioner Fellowship from the National Health and Medical Research Council. Dr Lau is supported by a Mid-Career Fellowship from the Hospital Research Foundation. Dr Sanders has served on the advisory boards of Biosense Webster, Medtronic, Abbott, Boston Scientific, and CathRx; has received lecture and/or consulting fees to the University of Australia from Biosense Webster, Medtronic, Abbott, and Boston Scientific; and has received research funding to the University of Australia from Medtronic, Abbott, BD, Boston Scientific, Biotronik, and MicroPort CRM. Dr Lau has received lecture and/or consulting fees to the University of Australia from Abbott Medical, Biotronik, Bristol Myers Squibb/Pfizer, Boehringer Ingelheim, Medtronic, and MicroPort CRM. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Drs Malik and Thiyagarajah are supported by an Australian Postgraduate Award Scholarship from the University of Adelaide. Dr Elliott is supported by a Future Leader Fellowship from the Heart Foundation of Australia. Dr Sanders is supported by a Practitioner Fellowship from the National Health and Medical Research Council. Dr Lau is supported by a Mid-Career Fellowship from the Hospital Research Foundation. Dr Sanders has served on the advisory boards of Biosense Webster, Medtronic, Abbott, Boston Scientific, and CathRx; has received lecture and/or consulting fees to the University of Australia from Biosense Webster, Medtronic, Abbott, and Boston Scientific; and has received research funding to the University of Australia from Medtronic, Abbott, BD, Boston Scientific, Biotronik, and MicroPort CRM. Dr Lau has received lecture and/or consulting fees to the University of Australia from Abbott Medical, Biotronik, Bristol Myers Squibb/Pfizer, Boehringer Ingelheim, Medtronic, and MicroPort CRM. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2022/8
Y1 - 2022/8
UR - http://www.scopus.com/inward/record.url?scp=85135939893&partnerID=8YFLogxK
U2 - 10.1016/j.jacep.2022.02.012
DO - 10.1016/j.jacep.2022.02.012
M3 - Letter
AN - SCOPUS:85135939893
SN - 2405-500X
VL - 8
SP - 1044
EP - 1046
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 8
ER -